CANITENOL PLUS 50mg/144mg/150mg tablets for dogs
CANITENOL PLUS 50mg/144mg/150mg tablets for dogs
Authorised
- Praziquantel
- Pyrantel embonate
- Febantel
Product identification
Medicine name:
CANITENOL PLUS 50mg/144mg/150mg tablets for dogs
Canitenol plus 50 mg/144 mg/150 mg comprimidos para cães
Active substance:
- Praziquantel
- Pyrantel embonate
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
-
Febantel150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Package description:
- box containing 10 strips of 10 tablets
- box containing 2 tiras of 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera d.d.
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 817/01/14DFVPT
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0211/001
Concerned member states:
-
Portugal
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 12/04/2023
Combined File of all Documents
English (PDF)
Download Published on: 24/07/2025
Portuguese (PDF)
Published on: 15/02/2024
Package Leaflet
English (PDF)
Download Published on: 27/06/2024
Labelling
English (PDF)
Download Published on: 27/06/2024